Attention to Retinoblastoma Diagnosed in the Trauma Setting
1 other identifier
observational
10
1 country
1
Brief Summary
To study the clinical characteristics and treatment outcomes of patients who experienced inadvertent trauma before diagnosis of retinoblastoma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2018
CompletedFirst Submitted
Initial submission to the registry
December 1, 2018
CompletedFirst Posted
Study publicly available on registry
December 5, 2018
CompletedDecember 5, 2018
December 1, 2018
5.6 years
December 1, 2018
December 4, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Survival Status
Outcome at last follow-up
between January 2013 and August 2018
Secondary Outcomes (2)
Trauma incidence of RB patients
between January 2013 and August 2018
RB incidence of pre-school patients with trauma history
between January 2013 and August 2018
Interventions
To study the clinical characteristics and treatment outcomes of patients who experienced inadvertent trauma before diagnosis of retinoblastoma.
Eligibility Criteria
Those children who experienced accidental ocular trauma with or without brain involvement before diagnosis of unsuspected RB was studied.
You may qualify if:
- The consecutive patients with RB managed at the ocular oncology service of Zhongshan Ophthalmic Center, Sun Yat-sen University, between January 2013 and August 2018.
You may not qualify if:
- The patients who didn't have undergone trauma before diagnosis of RB.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, 510000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Huasheng Yang, MD,PhD
Zhongshan Ophthalmic Center, Sun Yat-sen University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Orbital Diseases and Ocular Oncology, Clinical Professor
Study Record Dates
First Submitted
December 1, 2018
First Posted
December 5, 2018
Study Start
January 1, 2013
Primary Completion
August 1, 2018
Study Completion
November 30, 2018
Last Updated
December 5, 2018
Record last verified: 2018-12